Medications for Mediastinal Thymic Large Bcell Lymphoma

3 results

  • breyanzi

    (Lisocabtagene Maraleucel)
    Juno Therapeutics, Inc.
    Breyanzi is a CD19-directed CAR-T cell immunotherapy for adults with relapsed or refractory large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle cell lymphoma, or marginal zone lymphoma after 2 or more prior lines of therapy. Not indicated for primary CNS lymphoma.
    Medication Details

  • keytruda - pembrolizumab injection, powder, lyophilized, for solution

    (Pembrolizumab)
    Merck Sharp & Dohme Llc
    KEYTRUDA is a PD-1 blocking antibody that treats multiple cancers—including melanoma, lung, head and neck, bladder, colorectal, gastric, cervical, breast, and renal cancers—as well as MSI-H/dMMR and TMB-H solid tumors, used across neoadjuvant, adjuvant, and metastatic settings.
    Medication Details
    Drug Interactions

  • yescarta

    (Axicabtagene Ciloleucel)
    Kite Pharma, Inc.
    Yescarta is a CAR-T cell therapy for adults with large B-cell lymphoma refractory to or relapsing after first-line chemoimmunotherapy, or after two or more prior therapies. Also indicated for relapsed or refractory follicular lymphoma after two or more lines of systemic therapy (accelerated approval).
    Medication Details
    Drug Interactions